Next Med
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
NEWS
MILenARI Researcher Receives National Recognition in Immunology
The MILenARI consortium congratulates Dr. Manel Juan, principal investigator at IDIBAPS, the institution coordinating the project, on being named one of Spain's Best Doctors 2026 in the field of Immunology by El Confidencial.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
MILenARI highlights the crucial role of research on World Cancer Research Day
September 24th highlights the scientific advances that are transforming cancer care and improving patients' lives. The date commemorates the birth of Spanish Nobel Laureate Severo Ochoa and highlights the crucial role of research in the fight against cancer.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
Pediatric Cancer Awareness Month: MILenARI brings CAR-T Therapies Closer to Children with Leukemia
Every September, Childhood Cancer Awareness Month highlights the challenges faced by children and families affected by cancer, while also recognising the importance of research and innovation in developing new treatment options.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
How are lentiviral vectors sent across the Mediterranean region? MILenARI overcoming an invisible challenge
When we talk about international research projects, we usually focus on scientific results, innovation, and collaboration. However, an important part of research often goes unnoticed: how knowledge and research materials move from one country to another.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
American University of Beirut and MILenARI: Expanding access to CAR-T Cell Therapy
We speak with professors Ali Bazarbachi and Rami Mahfouz, of the American University of Beirut (AUB) about MILenARI and the university contribution to the project.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
MILenARI: Six months building a CAR-T Mediterranean network
Six months after the kick-off meeting that launched the project, MILenARI reaches its first milestone. This summer, the cross-border Mediterranean network moves from the initial setup to a fully active phase.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
MILenARI prepares for its first lentiviral vector shipments across the Mediterranean
After months of coordination and logistical preparations, the first international shipments of lentiviral vectors are expected to take place this July. The shipments represent a major milestone in the project's mission to transfer CAR-T technology across the Mediterranean region.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
The key role of vectors in the MILenARI project for cancer therapies
Vectors are one of the essential elements of the MILenARI project, as they make it possible to share CAR-T technology among the different Mediterranean countries participating in the initiative.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
MILenARI, transferring knowledge on access to CAR-T therapies
Access to CAR-T therapies continues to show differences between countries, highlighting inequalities in the availability of these treatments. The MILenARI project aims to democratize this access among Mediterranean countries.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region